Skip to main content

Ozempic (semaglutide) shortage

The current Ozempic (semaglutide) supply situation

Novo Nordisk have informed the Therapeutic Goods Administration (TGA) that Ozempic (semaglutide) will not be available in Australia from mid-November 2022 until the end of March 2023.

Therefore, we recommend that patients who are prescribed Ozempic should contact their doctor immediately to have their treatment reassessed. This is especially important as we approach the holiday season and medical services will be limited for several weeks.

The TGA is working with Novo Nordisk and the relevant health professional organisations to manage this serious shortage. The Royal Australian College of General Practitioners (RACGP) has published new advice for health professionals who have patients affected by the shortage of Ozempic.

The TGA will publish updates about the supply of Ozempic from Novo Nordisk on the Medicine Shortage Reports Database.

Published
Last updated

Help us improve the Therapeutic Goods Administration site